Department of Nephrology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Nephrology (Carlton). 2012 May;17(4):330-7. doi: 10.1111/j.1440-1797.2012.01577.x.
Despite significant advances in medical management and therapeutics, acute kidney injury (AKI) is still a common and serious complication with high morbidity and mortality in hospitalized patients, especially in patients admitted to the intensive care unit (ICU). The primary purpose of this study is to apply the definition proposed by the Acute Kidney Injury Network (AKIN) to investigate the incidence, 28-day mortality and risk factors for the prognosis of AKI in ICU.
In this retrospective study, data from a cohort of 4642 patients admitted to five ICUs were analyzed. Univariate and multivariate analyses were performed to investigate the risk factors for prognosis of AKI.
A total of 1036 patients were enrolled. AKI occurred in 353 of them (34.1%) under the AKIN criteria and the mortality was 54.4%. Multivariable analysis showed that variables related to the prognosis of AKI were: four or more (≥4) organ failed systems (odds ratio (OR) = 25.612), AKI III (OR = 14.441), AKI II (OR = 4.491), mechanical ventilation (OR = 7.201), sepsis (OR = 4.552), severe acute pancreatitis (OR = 3.299), base serum creatinine (OR = 1.004) and the length of stay in ICU (OR = 1.050).
For critically ill patient, the ICU mortality of AKI was correlated with various independent risk factors, especially AKI II, AKI III, severe acute pancreatitis and multiple organ failed systems.
尽管在医学管理和治疗方面取得了重大进展,但急性肾损伤(AKI)仍然是住院患者中常见且严重的并发症,发病率和死亡率都很高,尤其是在重症监护病房(ICU)住院的患者。本研究的主要目的是应用急性肾损伤网络(AKIN)提出的定义,调查 ICU 中 AKI 的发病率、28 天死亡率和预后的危险因素。
在这项回顾性研究中,分析了 5 个 ICU 中 4642 例患者的数据。进行了单因素和多因素分析,以调查 AKI 预后的危险因素。
共纳入 1036 例患者。根据 AKIN 标准,其中 353 例(34.1%)发生 AKI,死亡率为 54.4%。多变量分析表明,与 AKI 预后相关的变量有:4 个或更多(≥4)器官衰竭系统(优势比(OR)=25.612)、AKI III(OR=14.441)、AKI II(OR=4.491)、机械通气(OR=7.201)、脓毒症(OR=4.552)、重症急性胰腺炎(OR=3.299)、基础血清肌酐(OR=1.004)和 ICU 住院时间(OR=1.050)。
对于危重症患者,AKI 的 ICU 死亡率与各种独立危险因素相关,尤其是 AKI II、AKI III、重症急性胰腺炎和多器官衰竭系统。